Successful treatment of dermatomyositis and associated calcinosis with adalimumab.

Xie, F; Williams, P; Batchelor, R; Downs, A; Haigh, R

Xie, F; Williams, P; Batchelor, R; Downs, A; Haigh, R.

Affiliation

Xie F; Departments of, Department of, Dermatology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Williams P; Departments of, Department of, Dermatology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Batchelor R; Departments of, Department of, Dermatology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Downs A; Departments of, Department of, Dermatology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Haigh R; Department of, Rheumatology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.

Clin Exp Dermatol ; 45(7): 945-949, 2020 Oct.

Article in En | MEDLINE | ID: mdl-33448458

Subject(s)

Adalimumab/therapeutic use; Calcinosis/etiology; Dermatomyositis/drug therapy; Calcinosis/diagnostic imaging; Calcinosis/drug therapy; Dermatomyositis/complications; Exanthema/etiology; Extremities/diagnostic imaging; Female; Humans; Radiography; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcinosis / Dermatomyositis / Adalimumab Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Clin Exp Dermatol Year: 2020 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google